Suchergebnisse - "Xu, Ling-Jun"

PubPharm (6)

1

SP1-stimulated miR-208a-5p aggravates sepsis-induced myocardial injury via targeting XIAP

enthalten in: Experimental cell research | 2024

von Xu, L. | Yang, Y. | Yuan, L. | +4

2

Reduction of SIRT1-Mediated Epigenetic Upregulation of Nav1.7 Contributes to Oxaliplatin-Induced Neuropathic Pain

enthalten in: Pain physician | 2023

von Xu, L. | Wang, J. | Li, Y. | +4

3

Bim- and Bax-mediated mitochondrial pathway dominates abivertinib-induced apoptosis and ferroptosis

enthalten in: Free radical biology & medicine | 2022

von Tang, Q. | Chen, H. | Mai, Z. | +7

4

Reduction of SIRT1 Mediates Monosodium Iodoacetate-Induced Osteoarthritic Pain by Upregulating p53 Expression in Rats

enthalten in: Pain physician | 2021

von Xu, L. | Liu, C. | Chen, L. | +2

5

Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk : A meta-analysis and re-analysis of systematic meta-analyses

enthalten in: Medicine | 2021

von Zhang, W. | Yang, C. | Xu, L. | +3

6

Yangfei Kongliu Formula, a compound Chinese herbal medicine, combined with cisplatin, inhibits growth of lung cancer cells through transforming growth factor-β1 signaling pathway

enthalten in: Journal of integrative medicine | 2017

von Shen, S. | Zhang, Y. | Gu, X. | +2

1
[1]